| CHINA-DISTRIBUTORS |
CHINA-DISTRIBUTORS |
92%
|
Two customers, our China distributors who sell into China and Hong Kong, accounted for approximately 32% of our consolidated net sales during fiscal 2025. |
| KOREA-DISTRIBUTOR |
KOREA-DISTRIBUTOR |
92%
|
The Company's Korea distributor accounted for 18% of net sales for the three months ended March 28, 2025. |
| JNJ |
Johnson & Johnson |
72%
|
Reciprocal relationship from JNJ graph: Reciprocal relationship from STAA graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from STAA graph: Reciprocal relationship from JNJ grap… |
| JNJ |
Johnson & Johnson |
72%
|
Accordingly, our distributors in China held, as of December 27, 2024, elevated levels of ICL product inventory. Given the size of the Company’s business in China relative to its net sales in the rest… |
| ALLIANZ-SUISSE-LIFE-INSURANCE-COMPANY |
ALLIANZ-SUISSE-LIFE-INSURANCE-COMPANY |
62%
|
ed on the expected asset allocation and assumptions concerning long-term interest rates, inflation rates, and risk premiums for equities above the risk-free rates of return. These assumptions take in… |
| BIOTECH-VISION-CARE-CARE-GROUP |
BIOTECH-VISION-CARE-CARE-GROUP |
62%
|
emote working arrangements, changes to manufacturing work areas, such as adherence to social distancing guidelines, and other workforce changes will impact operational efficiency or inventory levels;… |
| CARL-ZEISS-MEDITEC-AG |
CARL-ZEISS-MEDITEC-AG |
62%
|
emote working arrangements, changes to manufacturing work areas, such as adherence to social distancing guidelines, and other workforce changes will impact operational efficiency or inventory levels;… |
| DIRECTORS-STAAR-SURGICAL-COMPANY |
DIRECTORS-STAAR-SURGICAL-COMPANY |
62%
|
sult in the re-measurement of our foreign currency denominated cash, receivables, and payables, generating currency transaction gains or losses and are reported in total other income, net in our Cons… |
| MARKET-SCOPE-LLC |
MARKET-SCOPE-LLC |
62%
|
an ICL for hyperopia, which treats farsightedness, is sold primarily in countries that require the European Union CE Mark. In July 2020, we received the CE Mark for EVO Viva , a presbyopia-correcting… |
| STAAR-AG |
STAAR-AG |
62%
|
ted to tax holidays $ ( 1,894 ) $ 4,466 $ 8,683 Impact of tax holidays on diluted earnings (loss) per share $ ( 0.04 ) $ 0.09 $ 0.17 Uncertain Tax Benefits A reconciliation of the beginning and endin… |
| STAAR-SURGICAL-AG |
STAAR-SURGICAL-AG |
62%
|
d vision). Not all of our products are currently available in all markets where we sell ICLs today. STAAR employs a commercialization strategy that strives for sustainable, profitable growth. Our gro… |
